Sir Richard Sykes, Chairman Glaxo SmithKline

Topics discussed include:

impressions of Wellcome generally and assessment of the company prior to the merger in 1995;

relationship between WT and company;

the merger; assessment of Glaxo prior to merger;

Zantac;

research;

relationship between Wellcome in UK and USA;

Zovirax; staff selection post-merger;

general discussion re pharmaceutical industry.

22 Oct 2001

2 audio tapes and transcript Tape 46

This item needs to be accessed onsite using specialist equipment. Email collections@wellcomecollection.org to request an appointment.